The use of clobetasol for therapy of lichen ruber planus
- Authors: Nazhmutdinova DK1
-
Affiliations:
- ГОУ ВПО «Российский государственный медицинский университет им. Н.И. Пирогова»
- Issue: Vol 87, No 1 (2011)
- Pages: 81-82
- Section: Articles
- URL: https://journals.rcsi.science/0042-4609/article/view/117371
- DOI: https://doi.org/10.25208/vdv969
- ID: 117371
Cite item
Full Text
Abstract
Data of the literature regarding the use of clobetasol propionate for treatment of lichen ruber planus are represented. The results of authors' comparative investigations for assessment of treatment efficacy using clobetasol propionate and betamethasone valerate in patients suffering lichen ruber planus demonstrated an advantage of the use of clobetasol propionate.
Keywords
About the authors
D K Nazhmutdinova
ГОУ ВПО «Российский государственный медицинский университет им. Н.И. Пирогова»
Email: dermatology@mail.ru
доцент кафедры дерматовенерологии лечебного факультета, к.м.н.; ГОУ ВПО «Российский государственный медицинский университет им. Н.И. Пирогова»
References
- Дерматовенерология, 2008 /под ред. А. А. Кубановой. (Клинические рекомендации/Российское общество дерматовенерологов). М.: ДЭКС-Пресс, 2008; 368.
- Carrozzo M., Thorpe R. Oral lichen planus: a review. Minerva Stom- atol 2009; (58): 519-537.
- Delavarian Z., Javadzadeh-Bolouri A. et al. The evaluation of psychiatric drug therapy on oral lichen planus patients with psychiatric disorders. Med Oral Pathol. Oral Cir Bucal 2010; (15): 322-327.
- Pokupec J. S., Gruden V., Gruden V. Jr. Lichen ruber planus as a psychiatric problem. Psychiatr. Danub 2009; (21): 514-516.
- Walton K. E., Bowers E. V., Drolet B. A., Holland K. E. Childhood lichen planus: demographics of a U. S. population. Pediatr Dermatol 2010; (27): 34-38.
- Feldman S. R. Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial Cutis 2007; (80,5 Suppl): 20-28.
- Feldman S. R., Koo J. Y., Johnson L. A., Preston N. J. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis. Cutis 2009; (84,4 Suppl.): 25-32.
- Kimball A. B., Gold M. H., Zib B., Davis M. W. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open- label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol 2008; (59): 448-454.
- Menter A., Abramovits W., Colon L. E. et al. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis. J Drugs Dermatol 2009; (8): 52-57.
- Gonzalez-Moles M. A., Morales P., Rodriguez-Archilla A. et al. Treatment of severe chronic oral erosive lesions with clobetasol propionate in aqueous solution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol Endocr 2002; (93): 264-70.
- Lo Muzio L., della Valle A., Mignogna M. D. et al. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med 2001; (30): 611-617.
Supplementary files
